Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial
By Reuters
·
2026-06-06
·
via Company News: Companies Analysis, Updates & Insights | The HinduBusinessLine
The drugmaker aims for berobenatide to be the first monthly GLP-1 weight-loss injection, distinguishing it fr…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。